Clinical Trials Browser

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × troxacitabine × Clear all

NCT00012259 2021-06-10

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

Phase 2 Completed

MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive